Immix Biopharma IMMX
NASDAQ IMMX
$8.66 +0.31 (+3.71%)
At close: Nov 11, 2026 · 4:00 PM EST

Immix Biopharma (IMMX) Change in Accrued Expenses (2021 - 2026)

Updated

Immix Biopharma's Change in Accured Expenses came in at -$1.23 million for Q2 2026, compared with $524,186 a year earlier.

Analysis

Immix Biopharma (IMMX) Change in Accrued Expenses (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Immix Biopharma reported Change in Accured Expenses of -$549,166; for FY2025, it came in at $1.03 million, down 76.7% from FY2024.

  • Change in Accured Expenses carries a five-year compound annual growth rate of 59.0% (FY2020 to FY2025).
  • Going back by year, Change in Accured Expenses was $4.4 million in FY2024 (+80.8%), $2.43 million in FY2023 (+115.1%), $1.13 million in FY2022 (+841.9%) and $120,154 in FY2021 (+18.9%).
  • The Q2 2026 figure represents the lowest quarterly Change in Accured Expenses since Q2 2024.
  • Year-over-year, Change in Accured Expenses increased in three of the last five quarters, with growth averaging 88.4%.
  • The fastest year-over-year change in Change in Accured Expenses over five years came in Q1 2024 (growth of 908.7%), and the weakest in Q1 2025 (a decline of 86.6%).
  • Business Quant data shows IMMX's Change in Accured Expenses at $432,207 (Q1 2026), -$790,864 (Q4 2025) and $1.04 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Immix Biopharma 597.32 Mn 365.22 Mn - -1.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.23 Mn
Mar 31, 2026 432,207.00
Dec 31, 2025 -790,864.00
Sep 30, 2025 1.04 Mn
Jun 30, 2025 524,186.00
Mar 31, 2025 258,718.00
Dec 31, 2024 2.28 Mn
Sep 30, 2024 2.00 Mn
Jun 30, 2024 -1.80 Mn
Mar 31, 2024 1.92 Mn
Dec 31, 2023 854,219.00
Sep 30, 2023 451,957.00
Jun 30, 2023 937,485.00
Mar 31, 2023 190,806.00
Dec 31, 2022 624,791.00
Sep 30, 2022 -330,542.00
Jun 30, 2022 676,562.00
Mar 31, 2022 160,925.00
Dec 31, 2021 -80,680.00
Sep 30, 2021 267,467.00
API Access

Immix Biopharma Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=IMMX&period=max&api_key=YOUR_API_KEY